Towards imaging criteria that best differentiate MS from NMOSD and MOGAD: Large multi-ethnic population and different clinical scenarios

Edgar Carnero Contentti; Juan Ignacio Rojas; Juan Criniti; Pablo A. López; Vanessa Daccach Marques; Ibis Soto de Castillo; Verónica Tkachuk; Mariano Marrodán; Jorge Correale; Mauricio Farez; Ho Jin Kim; Jae‐Won Hyun; Silvia Messina; Romina Mariano; Maria A. Rocca; Laura Cacciaguerra; Massimo Filippi; Jacqueline Palace; Maciej Juryńczyk

doi:10.1016/j.msard.2022.103778

Back

Towards imaging criteria that best differentiate MS from NMOSD and MOGAD: Large multi-ethnic population and different clinical scenarios

Article 2022 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2016

Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis

Sayonara Rangel Oliveira, Ana Paula Kallaur, Edna Maria Vissoci Reiche, Damacio Ramón Kaimen-Maciel, Carolina Panis, Marcell Alysson Batisti Lozovoy, Helena Kaminami Morimoto, Michael Maes, Isaías Dichi, Andréa Name Colado Simão

Preprint2019

True and False Positive Rates for Different Criteria of Evaluating Statistical Evidence from Clinical Trials

Don van Ravenzwaaij, John P A Ioannidis

Preprint2018

True and False Positive Rates for Different Criteria of Evaluating Statistical Evidence from Clinical Trials

Don van Ravenzwaaij, John P A Ioannidis

Article2019

True and false positive rates for different criteria of evaluating statistical evidence from clinical trials

Don van Ravenzwaaij, John P A Ioannidis

Preprint2019

True and False Positive Rates for Different Criteria of Evaluating Statistical Evidence from Clinical Trials

Don van Ravenzwaaij, John P A Ioannidis